Thy P Nguyen1, Suur Biliciler, Wojciech Wiszniewski, Kazim Sheikh. 1. *Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX; and †Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Abstract
OBJECTIVE: In the past decade, hereditary forms of motor neuron disease (spinal muscular atrophy and/or amyotrophic lateral sclerosis) are increasingly identified. As advanced genetic testing is performed, molecular diagnosis can be obtained. Identifying new gene mutations can lead to further understanding of disease. METHODS AND RESULTS: We report a single case of a patient with early-onset amyotrophic lateral sclerosis, evaluated at University of Texas Health Houston Science Center from 2011-2014. Initial genetic testing did not reveal an etiology in this patient. Through whole-exome sequencing, a VRK1 mutation was identified. CONCLUSIONS AND RELEVANCE: We identify a possible new cause of hereditary amyotrophic lateral sclerosis, VRK1 mutation. This case report also expands the phenotypic spectrum of this mutation in neurologic diseases.
OBJECTIVE: In the past decade, hereditary forms of motor neuron disease (spinal muscular atrophy and/or amyotrophic lateral sclerosis) are increasingly identified. As advanced genetic testing is performed, molecular diagnosis can be obtained. Identifying new gene mutations can lead to further understanding of disease. METHODS AND RESULTS: We report a single case of a patient with early-onset amyotrophic lateral sclerosis, evaluated at University of Texas Health Houston Science Center from 2011-2014. Initial genetic testing did not reveal an etiology in this patient. Through whole-exome sequencing, a VRK1 mutation was identified. CONCLUSIONS AND RELEVANCE: We identify a possible new cause of hereditary amyotrophic lateral sclerosis, VRK1 mutation. This case report also expands the phenotypic spectrum of this mutation in neurologic diseases.
Authors: Claudia Gonzaga-Jauregui; Timothy Lotze; Leila Jamal; Samantha Penney; Ian M Campbell; Davut Pehlivan; Jill V Hunter; Suzanne L Woodbury; Gerald Raymond; Adekunle M Adesina; Shalini N Jhangiani; Jeffrey G Reid; Donna M Muzny; Eric Boerwinkle; James R Lupski; Richard A Gibbs; Wojciech Wiszniewski Journal: JAMA Neurol Date: 2013-12 Impact factor: 18.302
Authors: Alexandria C Linville; Amber B Rico; Helena Teague; Lucy E Binsted; Geoffrey L Smith; Jonas D Albarnaz; Matthew S Wiebe Journal: J Virol Date: 2022-05-11 Impact factor: 6.549
Authors: Gabrielle R Budziszewski; Yani Zhao; Cathy J Spangler; Katarzyna M Kedziora; Michael R Williams; Dalal N Azzam; Aleksandra Skrajna; Yuka Koyama; Andrew P Cesmat; Holly C Simmons; Eyla C Arteaga; Joshua D Strauss; Dmitri Kireev; Robert K McGinty Journal: Nucleic Acids Res Date: 2022-05-06 Impact factor: 19.160
Authors: Ana T Marcos; Elena Martín-Doncel; Patricia Morejón-García; Iñigo Marcos-Alcalde; Paulino Gómez-Puertas; María Segura-Puimedon; Lluis Armengol; José M Navarro-Pando; Pedro A Lazo Journal: Ann Clin Transl Neurol Date: 2020-05-04 Impact factor: 4.511
Authors: Marion Stoll; Hooiling Teoh; James Lee; Stephen Reddel; Ying Zhu; Michael Buckley; Hugo Sampaio; Tony Roscioli; Michelle Farrar; Garth Nicholson Journal: Neurology Date: 2016-06-08 Impact factor: 9.910